Molecular and Cellular Pharmacology, Vol 10, No 3 (2018)

Font Size:  Small  Medium  Large

FDA Approves First Treatment for Advanced Form of the Second Most Common Skin Cancer

FDA News Release

Abstract


The U.S. Food and Drug Administration today approved Libtayo (cemiplimab-rwlc) injection for intravenous use for the treatment of patients with metastatic cutaneous squamous cell carcinoma (CSCC) or locally advanced CSCC who are not candidates for curative surgery or curative radiation. This is the first FDA approval of a drug specifically for advanced….


Full Text: PDF


LumiText Publishing, P.O. Box 774, Ellicott City, MD 21041 

Copyright © 2008 LumiText Publishing. All rights reserved.